Correlation Between Parksystems Corp and AptaBio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Parksystems Corp and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Parksystems Corp and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Parksystems Corp and AptaBio Therapeutics, you can compare the effects of market volatilities on Parksystems Corp and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Parksystems Corp with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Parksystems Corp and AptaBio Therapeutics.

Diversification Opportunities for Parksystems Corp and AptaBio Therapeutics

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Parksystems and AptaBio is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Parksystems Corp and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Parksystems Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Parksystems Corp are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Parksystems Corp i.e., Parksystems Corp and AptaBio Therapeutics go up and down completely randomly.

Pair Corralation between Parksystems Corp and AptaBio Therapeutics

Assuming the 90 days trading horizon Parksystems Corp is expected to generate 1.03 times more return on investment than AptaBio Therapeutics. However, Parksystems Corp is 1.03 times more volatile than AptaBio Therapeutics. It trades about 0.1 of its potential returns per unit of risk. AptaBio Therapeutics is currently generating about -0.1 per unit of risk. If you would invest  19,200,000  in Parksystems Corp on October 5, 2024 and sell it today you would earn a total of  3,550,000  from holding Parksystems Corp or generate 18.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Parksystems Corp  vs.  AptaBio Therapeutics

 Performance 
       Timeline  
Parksystems Corp 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Parksystems Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Parksystems Corp sustained solid returns over the last few months and may actually be approaching a breakup point.
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Parksystems Corp and AptaBio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Parksystems Corp and AptaBio Therapeutics

The main advantage of trading using opposite Parksystems Corp and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Parksystems Corp position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.
The idea behind Parksystems Corp and AptaBio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data